Obesity-Linked Gaps in Pulmonary Embolism Management – Shared by Zain Khalpey
Zain Khalpey, Chief Medical AI Officer, Chair of Applied Clinical AI, Director, Khalpey AI Lab at ATARI AI, posted on LinkedIn:
”Obesity changes everything about pulmonary embolism from diagnosis to drug dosing.
This new JACC review highlights how body size complicates imaging accuracy, influences anticoagulant and interventional choices, and even shapes outcomes through the “obesity paradox.”
The takeaway is clear: one size fits all guidance doesn’t work.
We need pragmatic, obesity-aware protocols and updated guidelines that reflect real world patients.
Full review here.
Follow Zain Khalpey for more on AI and Healthcare.”
Title: Obesity and Acute Pulmonary Embolism: Clinical Implications and Knowledge Gaps
Authors: Marco Zuin, Gregory Piazza, Stefano Barco, Laurent Bertoletti, Michal Ciurzynski, Nika Skoro-Sajer, Marcin Kurzyna, Sophia Anastasia Mouratoglou, Lukas Hobohm, Frederikus A. Klok

Keep up with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation